Alexander Fosså

11PUBLICATIONS

87CO-AUTHORS

Haematological tumoursDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutritional epidemiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 25, 2026

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

|Apr 08, 2026

Self-reported late effects and chronic fatigue, information needs and follow-up in long-term survivors of Hodgkin lymphoma-a cross-sectional study.

Lise H Willumsen, Knut B Smeland, Siri Eikeland

|Aug 29, 2025

Effects of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Chronic Fatigue: Protocol for a Randomized Controlled Trial (REFUEL).

Synne-Kristin Hoffart Bøhn, Kristin V Reinertsen, Cecilie E Kiserud

|Aug 20, 2025

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients.

Paul J Bröckelmann, Boris Böll, Daniel Molin

|Mar 24, 2025

Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial.

Alexander Fosså, Daniel Molin, Paul J Bröckelmann

|Feb 14, 2025

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.

Sheila K Pierson, Joshua D Brandstadter, Drew A Torigian

Pageof 2

Frequent Collaborators

Knut Bjøro Smeland

Cecilie E Kiserud

Unn-Merete Fagerli

Carsten Kobe

Ingrid Glimelius

Tone Skaali

Sandra Eloranta

Sirpa M Leppä

Caroline E Weibull

Anna Marklund

Frequent Collaborators

Knut Bjøro Smeland

Cecilie E Kiserud

Unn-Merete Fagerli

Carsten Kobe